Clinical Trial - Open Label Safety Study in Acute Treatment of Migraine - Migraine

  • 1

1 Answer

These messages are for mutual support and information sharing only. Always consult your doctor before trying anything you read here.
The purpose of this study is to evaluate safety and tolerability of BHV3000 (rimegepant).  
Study Type: Interventional  (Clinical Trial)
Estimated Enrollment: 210 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Care Provider)
Primary Purpose: Prevention
Official Title: Melatonin for Adolescent Migraine Prevention Study (The MAP Study).
Actual Study Start Date: *August 2, 2017
Estimated Primary Completion Date: *June 2021
Estimated Study Completion Date: *June 2021
Contact: Amy A Gelfand, MD 415-885-7832
Contact: Laura A Dapkus, NCPT 415-885-7832 Identifier: NCT03150797
  For enrollment please visit